[Clinical trials concerning the ataraxic and anxiolytic action of KT-5].
D014151:Anti-Anxiety Agents; D001007:Anxiety / Q000628:therapy*; D001008:Anxiety Disorders; D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder; D006801:Humans; D009497:Neurotic Disorders / Q000628:therapy*; D010276:Parasympatholytics / Q000628:therapy*; D011600:Psychopharmacology
D014151:Anti-Anxiety Agents; D010276:Parasympatholytics
ANXIETY/therapy; DEPRESSION/therapy; NEUROSES/therapy; PARASYMPATHOLYTICS/therapy; PSYCHOPHARMACOLOGY